DK1250600T3 - Diagnosticering af tauopatier ved bestemmelse af tau/phospho-tau-forholdet - Google Patents
Diagnosticering af tauopatier ved bestemmelse af tau/phospho-tau-forholdetInfo
- Publication number
- DK1250600T3 DK1250600T3 DK01909655T DK01909655T DK1250600T3 DK 1250600 T3 DK1250600 T3 DK 1250600T3 DK 01909655 T DK01909655 T DK 01909655T DK 01909655 T DK01909655 T DK 01909655T DK 1250600 T3 DK1250600 T3 DK 1250600T3
- Authority
- DK
- Denmark
- Prior art keywords
- tau
- phospho
- diagnosis
- tauopathies
- determining
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
- G01N2800/2821—Alzheimer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Neurology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Veterinary Medicine (AREA)
- Biotechnology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00870008 | 2000-01-24 | ||
US17839100P | 2000-01-27 | 2000-01-27 | |
EP00870280 | 2000-11-22 | ||
PCT/EP2001/000560 WO2001055725A2 (fr) | 2000-01-24 | 2001-01-18 | Diagnostic des tauopathies |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1250600T3 true DK1250600T3 (da) | 2007-02-05 |
Family
ID=27223742
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK01909655T DK1250600T3 (da) | 2000-01-24 | 2001-01-18 | Diagnosticering af tauopatier ved bestemmelse af tau/phospho-tau-forholdet |
Country Status (13)
Country | Link |
---|---|
US (2) | US6680173B2 (fr) |
EP (1) | EP1250600B1 (fr) |
JP (1) | JP5247963B2 (fr) |
AT (1) | ATE342509T1 (fr) |
AU (1) | AU777837B2 (fr) |
BR (1) | BR0107851A (fr) |
CA (1) | CA2397991C (fr) |
CY (1) | CY1107993T1 (fr) |
DE (2) | DE1250600T1 (fr) |
DK (1) | DK1250600T3 (fr) |
ES (1) | ES2274869T3 (fr) |
HK (1) | HK1048513B (fr) |
WO (1) | WO2001055725A2 (fr) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030162230A1 (en) * | 2000-09-27 | 2003-08-28 | Reagan Kevin J. | Method for quantifying phosphokinase activity on proteins |
JP4681175B2 (ja) * | 2001-09-28 | 2011-05-11 | 三菱化学メディエンス株式会社 | 播種性血管内凝固症候群及びその発症前段階を検出する方法 |
ES2352668T3 (es) * | 2002-08-14 | 2011-02-22 | Mitsubishi Chemical Medience Corporation | Anticuerpo específico para una proteína tau del sistema nervioso central. |
WO2004081534A2 (fr) * | 2003-03-12 | 2004-09-23 | Assay Designs, Inc. | Dosage de phosphokinase |
US7619059B2 (en) * | 2003-07-29 | 2009-11-17 | Life Technologies Corporation | Bimolecular optical probes |
US7727752B2 (en) * | 2003-07-29 | 2010-06-01 | Life Technologies Corporation | Kinase and phosphatase assays |
CA2445420A1 (fr) * | 2003-07-29 | 2005-01-29 | Invitrogen Corporation | Tests de kinase et de phosphatase |
US7238788B2 (en) * | 2004-02-18 | 2007-07-03 | University Of Iowa Foundation | Antibodies to phosphorylated tau, methods of making and methods of use |
JP4730584B2 (ja) | 2004-12-06 | 2011-07-20 | 東亞合成株式会社 | 抗菌ペプチド及びその利用 |
WO2007068105A1 (fr) * | 2005-12-12 | 2007-06-21 | Robarts Research Institute | PROCEDE DE DIAGNOSTIC DE LA SCLEROSE LATERALE AMYOTROPHIQUE <JavaScript:affichage('1','8870396','FRA','','1')> |
WO2009143380A2 (fr) * | 2008-05-21 | 2009-11-26 | Neurotez, Inc. | Procédés de traitement de troubles cognitifs progressifs liés à la dégénérescence neurofibrillaire |
WO2011045166A1 (fr) * | 2009-09-24 | 2011-04-21 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Interaction fkbp52-tau comme nouvelle cible thérapeutique pour traiter les troubles neurologiques mettant en jeu un dysfonctionnement de tau |
WO2011109112A2 (fr) * | 2010-03-05 | 2011-09-09 | Albert Einstein College Of Medicine Of Yeshiva University | Procédé de détection de la protéine tau et des fragments de tau dans le sérum |
US20130052669A1 (en) * | 2010-04-30 | 2013-02-28 | Amanda G. Paulovich | Compositions and methods for reliably detecting and/or measuring the amount of a modified target protein in a sample |
US8703137B2 (en) * | 2011-01-31 | 2014-04-22 | Intellect Neurosciences Inc. | Treatment of tauopathies |
WO2012142301A2 (fr) | 2011-04-12 | 2012-10-18 | Quanterix Corporation | Procédé de détermination d'un protocole de traitement et/ou d'un pronostic de rétablissement d'un patient à la suite d'un traumatisme cérébral |
GB201111361D0 (en) | 2011-07-04 | 2011-08-17 | Nordic Bioscience As | Biochemical markers for neurodegenerative conditions |
MY176838A (en) | 2012-08-16 | 2020-08-24 | Ipierian Inc | Methods of treating a tauopathy |
EP2893042B1 (fr) * | 2012-09-05 | 2018-02-14 | Emory University | Test de diagnostic de la démence et procédés associés |
US8980270B2 (en) | 2013-01-18 | 2015-03-17 | Ipierian, Inc. | Methods of treating a tauopathy |
EA039554B1 (ru) | 2013-06-10 | 2022-02-09 | АйПИЕРИАН, ИНК. | Способ снижения уровней a40 и/или a42 в нервной клетке и/или во внеклеточной жидкости |
MX2016007208A (es) | 2013-12-20 | 2016-07-21 | Hoffmann La Roche | Anticuerpos anti-tau(ps422) humanizados y metodos de uso. |
NZ630610A (en) | 2014-02-14 | 2019-05-31 | Ipierian Inc | Tau peptides, anti-tau antibodies, and methods of use thereof |
US10725054B2 (en) | 2014-04-08 | 2020-07-28 | University Of Florida Research Foundation, Incorporated | Protein biomarkers for acute, subacute and chronic traumatic injuries of the central nervous system |
AR100978A1 (es) | 2014-06-26 | 2016-11-16 | Hoffmann La Roche | LANZADERAS CEREBRALES DE ANTICUERPO HUMANIZADO ANTI-Tau(pS422) Y USOS DE LAS MISMAS |
DE102014013571A1 (de) * | 2014-09-18 | 2016-03-24 | Aj Roboscreen Gmbh | Monoklonaler Antikörper gegen humanes TAU-Protein |
ES2809728T3 (es) | 2015-06-24 | 2021-03-05 | Hoffmann La Roche | Anticuerpos anti-tau(pS422) humanizados y procedimientos de uso |
KR102033776B1 (ko) * | 2017-10-31 | 2019-10-17 | 가천대학교 산학협력단 | 타우 단백질의 발현수준을 측정하는 제제를 포함하는 알츠하이머 중증도 진단용 조성물 및 이를 이용한 알츠하이머 중증도의 진단방법 |
EA202092088A1 (ru) * | 2018-03-05 | 2020-11-13 | Янссен Фармацевтика Нв | Антитела анти-phf-тау и их применение |
EP3885362A4 (fr) * | 2018-11-22 | 2022-08-17 | Fujirebio Inc. | Conjugué d'anticorps |
JP2022527087A (ja) * | 2019-03-28 | 2022-05-30 | ハー・ルンドベック・アクチエゼルスカベット | タウオパチーを診断するためのpS396アッセイの使用 |
CA3135170A1 (fr) | 2019-04-05 | 2020-10-08 | Tauc3 Biologics Limited | Anticorps anti-tauc3 et leurs utilisations |
KR102633666B1 (ko) * | 2019-05-31 | 2024-02-06 | 일라이 릴리 앤드 캄파니 | 인간 타우를 표적화하는 화합물 및 방법 |
MX2022009607A (es) * | 2020-02-05 | 2022-09-02 | Sumitomo Pharma Co Ltd | Agente de determinacion y metodo de determinacion de taupatia y enfermedades relacionadas con la demencia. |
TW202344840A (zh) * | 2022-01-12 | 2023-11-16 | 英商Gt創新公司 | 診斷檢定 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993003369A1 (fr) * | 1991-08-01 | 1993-02-18 | Voorheis Paul H | Diagnostic de la maladie d'alzheimer |
JP2879975B2 (ja) * | 1992-12-14 | 1999-04-05 | エヌ・ブイ・インノジェネティクス・ソシエテ・アノニム | 微小管関連タンパク質タウに対するモノクローナル抗体、これらの抗体を分泌するハイブリドーマ、これらのモノクローナル抗体による抗原認識及びこれらの応用 |
JPH06239899A (ja) * | 1993-02-12 | 1994-08-30 | Teijin Ltd | ヒトタウ蛋白に対する抗体、並びに該抗体を利用する体液中のヒトタウ蛋白の測定方法 |
CA2178212C (fr) * | 1993-12-21 | 2011-06-14 | Marc Vandermeeren | Anticorps monoclonaux specifiques de phf-tau, hybridomes les secretant, reconnaissance des antigenes par ces anticorps et leurs applications |
US6121003A (en) * | 1994-07-29 | 2000-09-19 | Innogentics N.V. | Monoclonal antibodies specific for an epitope of phosphorylated tau, and their use |
WO1997034145A1 (fr) * | 1996-03-13 | 1997-09-18 | Mitsubishi Chemical Corporation | Anticorps a proteine tau antiphosphorylee et procede de detection de la maladie d'alzheimer l'utilisant |
AU4322999A (en) * | 1998-06-01 | 1999-12-20 | Advanced Research And Technology Institute, Inc. | Methods and compositions for diagnosing tauopathies |
-
2001
- 2001-01-18 CA CA2397991A patent/CA2397991C/fr not_active Expired - Lifetime
- 2001-01-18 JP JP2001555812A patent/JP5247963B2/ja not_active Expired - Lifetime
- 2001-01-18 DE DE1250600T patent/DE1250600T1/de active Pending
- 2001-01-18 AT AT01909655T patent/ATE342509T1/de active
- 2001-01-18 EP EP01909655A patent/EP1250600B1/fr not_active Expired - Lifetime
- 2001-01-18 ES ES01909655T patent/ES2274869T3/es not_active Expired - Lifetime
- 2001-01-18 DE DE60123752T patent/DE60123752T2/de not_active Expired - Lifetime
- 2001-01-18 AU AU37319/01A patent/AU777837B2/en not_active Expired
- 2001-01-18 DK DK01909655T patent/DK1250600T3/da active
- 2001-01-18 WO PCT/EP2001/000560 patent/WO2001055725A2/fr active IP Right Grant
- 2001-01-18 BR BR0107851-8A patent/BR0107851A/pt not_active Application Discontinuation
- 2001-01-24 US US09/769,180 patent/US6680173B2/en not_active Expired - Lifetime
-
2002
- 2002-11-15 HK HK02108310.4A patent/HK1048513B/zh not_active IP Right Cessation
-
2003
- 2003-10-09 US US10/682,103 patent/US7387879B2/en not_active Expired - Lifetime
-
2007
- 2007-01-11 CY CY20071100047T patent/CY1107993T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
CY1107993T1 (el) | 2013-09-04 |
US7387879B2 (en) | 2008-06-17 |
AU777837B2 (en) | 2004-11-04 |
US20030194742A1 (en) | 2003-10-16 |
CA2397991A1 (fr) | 2001-08-02 |
ATE342509T1 (de) | 2006-11-15 |
EP1250600B1 (fr) | 2006-10-11 |
AU3731901A (en) | 2001-08-07 |
WO2001055725A2 (fr) | 2001-08-02 |
DE60123752D1 (de) | 2006-11-23 |
JP2003521499A (ja) | 2003-07-15 |
CA2397991C (fr) | 2017-10-24 |
DE1250600T1 (de) | 2003-03-06 |
ES2274869T3 (es) | 2007-06-01 |
BR0107851A (pt) | 2002-10-29 |
HK1048513B (zh) | 2007-12-07 |
WO2001055725A3 (fr) | 2001-12-20 |
US6680173B2 (en) | 2004-01-20 |
US20040091942A1 (en) | 2004-05-13 |
HK1048513A1 (en) | 2003-04-04 |
JP5247963B2 (ja) | 2013-07-24 |
EP1250600A2 (fr) | 2002-10-23 |
DE60123752T2 (de) | 2007-08-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1250600T3 (da) | Diagnosticering af tauopatier ved bestemmelse af tau/phospho-tau-forholdet | |
ITTO20010411A0 (it) | Metodo e dispositivo per l'esecuzione di test e saggi ad alta processivita' ed alto valore biologico su cellule e/o composti. | |
HK1041920A1 (en) | Measurement and use of molecular interactions. | |
BRPI0412184A (pt) | renderização de anúncios com documentos tendo um ou mais tópicos utilizando informação de interesse de tópico do usuário | |
DK1372469T3 (da) | Fremgangsmåde til bestemmelse af de optiske egenskaber af et flerlaget væv | |
WO2002046746A3 (fr) | Procede de detection de metabolites de la vitamine d | |
RS50219B (sr) | Sistem analize | |
WO2002027326A3 (fr) | Procede et trousse pour la determination transdermique de la concentration d'une analyte dans le sang | |
WO2001032876A3 (fr) | Compositions et techniques permettant de determiner les interactions de composants mitochondriaux et d'identifier les agents modifiant ces interactions | |
WO2002008461A3 (fr) | Methodes d'analyse et d'identification de genes transcrits et empreinte genetique | |
WO2004094675A3 (fr) | Compositions et methodes permettant de determiner la presence de coronavirus du sras dans un echantillon | |
MXPA03003682A (es) | Metodo para determinar la coagulabilidad y el potencial hemostatico globales. | |
DK0539435T3 (da) | Fremgangsmåde til nedsættelse af interferenser ved en bestemmelse ved fluorescens | |
NO20015157L (no) | Fremgangsmåte ved bestemmelse av pre-neoplastiske og/eller neoplastiske tilstander hos pattedyr | |
WO2001086285A3 (fr) | Detection directe de molecules individuelles | |
BR0014626A (pt) | Análise de leptina | |
WO2002059600A3 (fr) | Detection d'analytes | |
BR0108042A (pt) | Membranas de limitação de difusão de analito fundido usando monÈmeros hidrófilos fotopolimerizáveis | |
WO2005037231A3 (fr) | Methodes de detection et de traitement de la myopathie facioscapulohumerale | |
CY1106705T1 (el) | Δοκιμασια για μετρηση ολο-τρανσκοβαλαμινης και φολικου | |
ATE253223T1 (de) | Verfahren und materialien zur diagnose instabiler angina | |
WO2002050543A3 (fr) | Systeme de detection d'une substance a analyser libre | |
ES2184109T3 (es) | Determinacion de analitos mediando utilizacion de dos marcaciones. | |
ES2172214T3 (es) | Procedimiento de identificacion de una imagen o de un documento. | |
TR200402036T4 (tr) | (-)-Cis-2-(2-Klorofenil)-5, 7-Dihidroksi-8-[4R-(3S-Hidroksi-1-Metil) Piperidinil]-4H-1- Benzopiran-4-on'un psödopolimorfu |